Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3849)
All Articles published online
|
Jun 1, 2004 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiang JT, Wu CP, Deng HF, Lu MY, Wu J, Zhang HY, Sun WH, Ji M. Serum level of TSGF, CA242 and CA19-9 in pancreatic cancer. World J Gastroenterol 2004; 10(11): 1675-1677 [PMID: 15162550 DOI: 10.3748/wjg.v10.i11.1675] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v10/i11/1675.htm |
| Number | Citing Articles |
| 1 |
Jesse Hinton, Richard Callan, Charlie Bodine, Wayne Glasgow, Steve Brower, Shi-Wen Jiang, Jinping Li. Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas. Expert Review of Molecular Diagnostics 2013; 13(5): 431 doi: 10.1586/erm.13.38
|
| 2 |
Guoxiang Xie, Lingeng Lu, Yunping Qiu, Quanxing Ni, Wei Zhang, Yu-Tang Gao, Harvey A. Risch, Herbert Yu, Wei Jia. Plasma Metabolite Biomarkers for the Detection of Pancreatic Cancer. Journal of Proteome Research 2015; 14(2): 1195 doi: 10.1021/pr501135f
|
| 3 |
Xiaoqin Xu, Weigang Wang, Ting Sun, Baoguo Tian, Lili Du, Jiexian Jing, Guangtao Xu. The Predicting Role of Serum TSGF and sIL-2R for the Lymph Node Metastasis of Papillary Thyroid Carcinoma. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/3730679
|
| 4 |
Gang Zhou, David Chiu, Dajiang Qin, Lizhi Niu, Jinlei Cai, Lihua He, Wenhao Huang, Kecheng Xu. The Efficacy Evaluation of Cryosurgery in Pancreatic Cancer Patients with the Expression of CD44v6, Integrin-β1, CA199, and CEA. Molecular Biotechnology 2012; 52(1): 59 doi: 10.1007/s12033-011-9474-7
|
| 5 |
Xueyan Li, Xiaozhong Guo, Hongyu Li, Hao Lin, Yingwei Sun. Serum carbohydrate antigen 242 expression exerts crucial function in the diagnosis of pancreatic cancer. Tumor Biology 2014; 35(6): 5281 doi: 10.1007/s13277-014-1687-5
|
| 6 |
Zhe Huang, Fang Liu. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis. Tumor Biology 2014; 35(8): 7459 doi: 10.1007/s13277-014-1995-9
|
| 7 |
Ji-Cong Gui, Wei-Li Yan, Xing-Dang Liu. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clinical and Experimental Medicine 2014; 14(2): 225 doi: 10.1007/s10238-013-0234-9
|
| 8 |
Liliane Benkoël, Jean-Paul Bernard, Marie-José Payan-Defais, Lydie Crescence, Cécile Franceschi, Mireille Delmas, Mehdi Ouaissi, Bernard Sastre, José Sahel, Anne-Marie Benoliel, Pierre Bongrand, Françoise Silvy, Laurent Gauthier, François Romagné, Dominique Lombardo, Eric Mas. Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues. Molecular Cancer Therapeutics 2009; 8(2): 282 doi: 10.1158/1535-7163.MCT-08-0471
|
| 9 |
Kamran Hosseini, Sohrab Minaei Beirami, Haleh Forouhandeh, Sepideh Zununi Vahed, Shirin Eyvazi, Fatemeh Ramazani, Vahideh Tarhriz, Mohammadreza Ardalan. The role of circadian gene timeless in gastrointestinal cancers. Gene Reports 2023; 30: 101722 doi: 10.1016/j.genrep.2022.101722
|
| 10 |
Akash Khandvi, Akshar M Chauhan, Neeru D Dave, Darshan D Dave. Comparative role of tumor marker CA 242 and CA 19.9 in various pancreatic lesions. Indian Journal of Pathology and Oncology 2023; 10(4): 346 doi: 10.18231/j.ijpo.2023.078
|
| 11 |
Y.-F. Chen, J.-Y. Wang, C.-H. Wu, F.-M. Chen, T.-L. Cheng, S.-R. Lin. Detection of circulating cancer cells with K-ras oncogene using membrane array. Cancer Letters 2005; 229(1): 115 doi: 10.1016/j.canlet.2004.12.026
|
| 12 |
Sukhwinder Kaur, Michael J Baine, Maneesh Jain, Aaron R Sasson, Surinder K Batra. Early diagnosis of pancreatic cancer: challenges and new developments. Biomarkers in Medicine 2012; 6(5): 597 doi: 10.2217/bmm.12.69
|
| 13 |
Subhankar Chakraborty, Michael J. Baine, Aaron R. Sasson, Surinder K. Batra. Current status of molecular markers for early detection of sporadic pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011; 1815(1): 44 doi: 10.1016/j.bbcan.2010.09.002
|
| 14 |
S. Bünger, T. Laubert, U. J. Roblick, J. K. Habermann. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. Journal of Cancer Research and Clinical Oncology 2011; 137(3): 375 doi: 10.1007/s00432-010-0965-x
|
| 15 |
Marcus Bahra, Florian Lordick, Manfred P. Lutz, Matthias Glanemann, Peter Neuhaus. Viszeralmedizin. 2015; : 557 doi: 10.1007/978-3-642-14301-4_38
|
| 16 |
Natalia Calanzani, Paige E. Druce, Claudia Snudden, Kristi M. Milley, Rachel Boscott, Dawnya Behiyat, Smiji Saji, Javiera Martinez-Gutierrez, Jasmeen Oberoi, Garth Funston, Mike Messenger, Jon Emery, Fiona M. Walter. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Advances in Therapy 2021; 38(2): 793 doi: 10.1007/s12325-020-01571-z
|
| 17 |
H. Oettle, A. Goerke, A. Kaiser, V. Budach, P. Vogel. Therapiekonzepte Onkologie. 2007; : 713 doi: 10.1007/978-3-540-28978-4_34
|
| 18 |
Ian D Norton. Pancreatic cancer: Tissue is the issue. Journal of Gastroenterology and Hepatology 2008; 23(4): 507 doi: 10.1111/j.1440-1746.2008.05399.x
|
| 19 |
Qingxi Zhang, Guo Dong, Fuchuan Wang, Wenyuan Ding. Correlation between the changes of serum COX 2, APE1, VEGF, TGF-β and TSGF levels and prognosis in patients with osteosarcoma before and after treatment. Journal of Cancer Research and Therapeutics 2020; 16(2): 335 doi: 10.4103/jcrt.JCRT_11_20
|
| 20 |
Si-Biao Su, Shan-Yu Qin, Wen Chen, Wei Luo, Hai-Xing Jiang. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World Journal of Gastroenterology 2015; 21(14): 4323-4333 doi: 10.3748/wjg.v21.i14.4323
|
| 21 |
Xiaoqin Xu, Weigang Wang, Baoguo Tian, Xiaofang Zhang, Yanfen Ji, Jiexian Jing. The predicting role of serum tumor-specific growth factor for prognosis of esophageal squamous cell carcinoma. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11602-x
|
| 22 |
Bo Deng, Qun-You Tan, Xiao-Qing Fan, Yao-Guang Jiang, Yun-Ping Zhao, Jing-Hai Zhou, Yong-Gang Liang, Ru-Wen Wang. Clinical Value of Assaying Tumor Supplied Group of Factor/Tumor Specific Growth Factor in Patients With Solitary Pulmonary Nodule. Clinical Lung Cancer 2011; 12(3): 192 doi: 10.1016/j.cllc.2011.03.017
|
| 23 |
Takashi Kobayashi, Shin Nishiumi, Atsuki Ikeda, Tomoo Yoshie, Aya Sakai, Atsuki Matsubara, Yoshihiro Izumi, Hidetaka Tsumura, Masahiro Tsuda, Hogara Nishisaki, Nobuhide Hayashi, Seiji Kawano, Yutaka Fujiwara, Hironobu Minami, Tadaomi Takenawa, Takeshi Azuma, Masaru Yoshida. A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(4): 571 doi: 10.1158/1055-9965.EPI-12-1033
|
| 24 |
Shuichi MITSUNAGA, Motohiro KOJIMA, Masafumi IKEDA, Atsushi OCHIAI. Serum microRNAs as tumor markers for diagnosis of pancreatic cancer. Suizo 2017; 32(1): 56 doi: 10.2958/suizo.32.56
|
| 25 |
Pengjiao Zeng, Hui Li, Yulong Chen, Haitao Pei, Lijuan Zhang. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part A. Progress in Molecular Biology and Translational Science 2019; 162: 253 doi: 10.1016/bs.pmbts.2018.12.010
|
| 26 |
Vitor Faca, Samir Hanash. In-depth quantitative proteomics for pancreatic cancer biomarker discovery. Expert Opinion on Medical Diagnostics 2007; 1(1): 81 doi: 10.1517/17530059.1.1.81
|
| 27 |
Piotr Hogendorf, Adam Durczyński, Aleksander Skulimowski, Anna Kumor, Grażyna Poznańska, Janusz Strzelczyk. Neutrophil Gelatinase-Associated Lipocalin (NGAL) concentration in urine is superior to CA19-9 and Ca 125 in differentiation of pancreatic mass: Preliminary report. Cancer Biomarkers 2016; 16(4): 537 doi: 10.3233/CBM-160595
|
| 28 |
Prathibha Ranganathan, H. C. Harsha, Akhilesh Pandey. Molecular Alterations in Exocrine Neoplasms of the Pancreas. Archives of Pathology & Laboratory Medicine 2009; 133(3): 405 doi: 10.5858/133.3.405
|
| 29 |
Jennifer M. Curry, Kyle J. Thompson, Shanti G. Rao, Dahlia M. Besmer, Andrea M. Murphy, Valery Z. Grdzelishvili, William A. Ahrens, Iain H. McKillop, David Sindram, David A. Iannitti, John B. Martinie, Pinku Mukherjee. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer. Journal of Surgical Oncology 2013; 107(7): 713 doi: 10.1002/jso.23316
|
| 30 |
B Yu, PZ Xu, QW Wang, H Zhou, HX Zhou. Clinical Value of Tumour Specific Growth Factor (TSGF) and Carbohydrate Antigen-125 (CA-125) in Carcinoma of the Endometrium. Journal of International Medical Research 2009; 37(3): 878 doi: 10.1177/147323000903700333
|
| 31 |
Yan Zhang, Guohong Li. A Novel Electrochemical Sensor Based on a Graphene-Silver Platform for the Sensitive Determination of a Tumor-Supplied Group of Factors. International Journal of Electrochemical Science 2017; 12(11): 10095 doi: 10.20964/2017.11.13
|
| 32 |
Anna S. Gerdtsson, Núria Malats, Anna Säll, Francisco X. Real, Miquel Porta, Petter Skoog, Helena Persson, Christer Wingren, Carl A. K. Borrebaeck. A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma. International Journal of Proteomics 2015; 2015: 1 doi: 10.1155/2015/587250
|
| 33 |
Niklas Sturm, Thomas J. Ettrich, Lukas Perkhofer. The Impact of Biomarkers in Pancreatic Ductal Adenocarcinoma on Diagnosis, Surveillance and Therapy. Cancers 2022; 14(1): 217 doi: 10.3390/cancers14010217
|
| 34 |
K.S. Goonetilleke, A.K. Siriwardena. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. European Journal of Surgical Oncology (EJSO) 2007; 33(3): 266 doi: 10.1016/j.ejso.2006.10.004
|
| 35 |
Gunnar Folprecht, Michael Geißler, Diana Lüftner, Helmut Öttle, Kurt Possinger, Anne C. Regierer. Facharzt Hämatologie Onkologie. 2007; : 573 doi: 10.1016/B978-343723770-6.50021-1
|
| 36 |
Siqi Yu, Guizheng Zou, Qin Wei. Ultrasensitive electrochemical immunosensor for quantitative detection of tumor specific growth factor by using Ag@CeO2 nanocomposite as labels. Talanta 2016; : 11 doi: 10.1016/j.talanta.2016.04.050
|
| 37 |
Julia Mayerle, Holger Kalthoff, Regina Reszka, Beate Kamlage, Erik Peter, Bodo Schniewind, Sandra González Maldonado, Christian Pilarsky, Claus-Dieter Heidecke, Philipp Schatz, Marius Distler, Jonas A Scheiber, Ujjwal M Mahajan, F Ulrich Weiss, Robert Grützmann, Markus M Lerch. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut 2018; 67(1): 128 doi: 10.1136/gutjnl-2016-312432
|
| 38 |
Pengjun Zhang, Meng Zou, Xinyu Wen, Feng Gu, Juan Li, Gaixia Liu, Jingxiao Dong, Xinxin Deng, Jing Gao, Xiaolong Li, Xingwang Jia, Zhennan Dong, Luonan Chen, Yong Wang, Yaping Tian. Development of serum parameters panels for the early detection of pancreatic cancer. International Journal of Cancer 2014; 134(11): 2646 doi: 10.1002/ijc.28584
|
| 39 |
Eseosaserea Igbinigie, Fengbiao Guo, Shi-Wen Jiang, Cullen Kelley, Jinping Li. Dkk1 involvement and its potential as a biomarker in pancreatic ductal adenocarcinoma. Clinica Chimica Acta 2019; 488: 226 doi: 10.1016/j.cca.2018.11.023
|
| 40 |
Yoshihito Ide, Eiji Miyoshi, Tsutomu Nakagawa, Jianguo Gu, Masahiro Tanemura, Toshiro Nishida, Toshinori Ito, Harumi Yamamoto, Yasunori Kozutsumi, Naoyuki Taniguchi. Aberrant expression of N-acetylglucosaminyltransferase-IVa and IVb (GnT-IVa and b) in pancreatic cancer. Biochemical and Biophysical Research Communications 2006; 341(2): 478 doi: 10.1016/j.bbrc.2005.12.208
|
| 41 |
Yao Wu, Bin Qu, Haoming Shen, Hongyu Deng, Faqin Tang. Serum Level of Tumor-Specific Growth Factor in Patients with Cervical Cancer and Its Potential Prognostic Role. Oncologie 2022; 24(3): 499 doi: 10.32604/oncologie.2022.024951
|
| 42 |
Robert S O'Neill, Alina Stoita. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 2021; 27(26): 4045-4087 doi: 10.3748/wjg.v27.i26.4045
|
| 43 |
|
| 44 |
Mark Bloomston, Tanios S. Bekaii-Saab, Kavitha Kosuri, Sarah M. Cowgill, W. Scott Melvin, E. Christopher Ellison, Peter Muscarella. Preoperative Carbohydrate Antigen 19-9 is Most Predictive of Malignancy in Older Jaundiced Patients Undergoing Pancreatic Resection. Pancreas 2006; 33(3): 246 doi: 10.1097/01.mpa.0000236726.34296.df
|
| 45 |
Gang Zhou, Lizhi Niu, David Chiu, Lihua He, Kecheng Xu. Changes in the expression of serum markers CA242, CA199, CA125, CEA, TNF-α and TSGF after cryosurgery in pancreatic cancer patients. Biotechnology Letters 2012; 34(7): 1235 doi: 10.1007/s10529-012-0908-5
|